Simply confirm your registered email address below and click "Reset Password." We will immediately email you a link back to the site where you can enter a new password for this account.
We've found your existing WIBC Email Club account. Please login below to complete the Facebook login process.
Attorney General Greg Zoeller wants the Indiana Pharmacy Board to suspend the license of a questionable Massachusetts pharmacy. The pharmacy is linked to the nationwide fungal meningitis outbreak.
Zoeller filed an emergency petition today (Friday). He says the New England Compounding Center produced the tainted steroid that has been linked to the meningitis cases. The non-resident pharmacy distributes its products in Indiana and has already suspended operations.
The Indiana Department of Health says the state now has 43 cases and three deaths linked to the nationwide outbreak. Zoeller says the NECC presents an immediate danger to public health and safety.
The Indiana Board of Pharmacy will consider the petition for license suspension at its next meeting November 5th. If the board grants the suspension, NECC would be banned from operating in Indiana for 90 days and Zoeller's office would file a formal licensing complaint.
MORE FROM WIBC NEWS:» Two More Fungal Meningitis Linked to Indiana (10-25-12)» A Third Fungal Meningitis Death Reported in Indiana (10-24-12) » Meningitis Outbreak "A Perfect Storm" Of Conditions According To Expert (10-16-12) » Second Death in Indiana from Fungal Meningitis Outbreak (10-13-12) » Three More Meningitis Cases Confirmed in Indiana (10-12-12) » Patient Injected in Indiana Becomes State's First Meningitis Death (10-11-12) » Number of Fungal Meningitis Cases Climbs to 11 in Indiana (10-8-12) » Fungal Meningitis Cases Jump In Indiana (10-7-12) » Cases of Fungal Meningitis Climbs to Three in Indiana (10-5-12) » Doctor Explains Fungal Meningitis (10-5-12) » Rare Fungal Meningitis Spreads to Indiana (10-4-12)
NOTE: This thread is moderated, comments will not post immediately.
Copyright by WIBC.com © 2012. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Copyright © 2013. All rights reserved.